December 7, 2017
Tresiba reduces hypoglycaemia regardless of blood sugar level
People with either type 1 or type 2 diabetes treated with Tresiba had fewer episodes of low blood sugar (hypoglycaemia) compared…
Pharmaceuticals, Biotechnology and Life Sciences
People with either type 1 or type 2 diabetes treated with Tresiba had fewer episodes of low blood sugar (hypoglycaemia) compared…
Switching to Tresiba from another basal insulin benefits people with diabetes regardless of whether or not their blood sugar levels…
China Food and Drug Administration (CFDA) has approved Novo Nordisk’s Tresiba (insulin degludec) for the treatment of diabetes in China.
The U.S. Food and Drug Administration has approved Tresiba (insulin degludec injection) and Ryzodeg 70/30 (insulin degludec/insulin aspart injection) to…